HAIs cost hospitals billions of dollars a year.
The direct medical cost of HAIs to health care facilities exceeds $11 billion annually.* Tru-D may lower the risk of patients developing unnecessary and preventable infections transmitted by the environment. Reducing the incidences of health care infections by eradicating the pathogens that lie hidden in health care environments is Tru-D’s assurance of an immediate cost avoidance.
Tru-D can save on your bottom line while improving patient outcomes.
With HAI rates increasing, more superbugs discovered each year and increased financial accountability for infection rates, it’s critical for hospitals to provide the cleanest environments possible to protect patients and staff from infections.
A recent randomized clinical trial has concluded enhanced disinfection protocols that include Tru-D in your bundling package of current infection prevention modalities (i.e. hand washing and manual disinfection) may reduce the relative risk of colonization and hospital-associated infections (HAIs) and fill the gap in your performance improvement plan.


Cost avoidance associated with HAIs support your efforts to measure quality and cost effectiveness to achieve improved outcomes.
Tru-D is the only device on the market that delivers measured dose of UVC light to all surfaces in every room, every time. We provide scientifically-validated efficacy and unmatchable efficiency to integrate into existing workflow, as well as a return on investment.
Contact us at info@tru-d.com to learn how Tru-D may help produce a minimum 20% cost avoidance for your facility.
*Source: www.cdc.gov, “The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention,” March 2009